Photo for representational purpose only.
Chandigarh, October 6
The authorities have taken the samples of cough syrup from a Sonepat-based factory, Maiden Pharmaceuticals, and sent to the Central drug laboratory, Kolkatta, for testing, Haryana Health Minister Anil Vij said on Thursday.
Based on the lab report, if anything is found amiss, strict action will be taken against the unit and its owners, said Vij.
The World Health Organisation (WHO) has warned that Maiden cough syrup could be linked to the deaths of 66 children in The Gambia.
A laboratory analysis of Maiden cough syrup had confirmed "unacceptable" amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury, the WHO said.
The Health Ministry here said it had already launched investigations into the matter and asked the WHO to provide the report establishing the link between the medicines in question and the stated mortality.
Tribune Shorts
Most Read
Don't Miss
View All
Top News
Tata group to merge Vistara with Air India; Singapore Airlines to buy 25.1 pc stake in Air India
Deal expected to be complete by March 2024 | Tata group owns...
UK delivering on new Free Trade Agreement with India, says Rishi Sunak
In his first major foreign policy speech since taking charge...
Days after ‘traitor’ slur, Gehlot and Pilot put up show of unity ahead of Rahul’s Bharat Jodo Yatra in Rajasthan
Asked to comment, Gandhi had told reporters in Indore on Mon...
'Truth can make people lie': Vivek Agnihotri takes indirect dig at IFFI jury head over 'The Kashmir Files' row
Actor Anupam Kher condemns Nadav Lapid’s controversial remar...
